Medpace Holdings, Inc.
MEDP
Rangering i aksjer
#1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aksjekurs
$622.03
Sist synkronisert: 2026-10-20
Markedsverdi
$17.36B
Endring (1 dag)
0.38%
Endring (1 år)
14.00%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Kategori
Healthcare
Historikk for aksjesplitt for Medpace Holdings, Inc. (MEDP)
Aksjen Medpace Holdings, Inc. (symbol: MEDP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MEDP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MEDP-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MEDP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MEDP-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|